Vertex's Non-Opioid Pain Drug Secures Coverage from UnitedHealth

Vertex Pharmaceuticals has marked a significant milestone in the pharmaceutical landscape by gaining coverage approval for its non-opioid pain management drug, known as exablate, from UnitedHealth Group. This development is seen as a promising step towards providing alternatives to patients who suffer from chronic pain conditions while mitigating the risks associated with opioid medications.

Continue reading